Rachel Kuchtey is an Ophthalmology physician affiliated with Vanderbilt University. OpenAlex indexes 87 publications with 1,896 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372320001
Telephone
615-322-3000Provider last certified this registry record 5 Feb 2026.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Glaukos CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
85.3%Prostaglandin Analog33.2%Latanoprost88%Lumigan9%Travoprost3%Part D≥215 patientsCarbonic Anhydrase Inhibitor25.5%Dorzolamide-Timolol66%Dorzolamide Hcl20%Simbrinza8%Brinzolamide2%Azopt2%Acetazolamide Er2%Part D<11 patients+ 5 more classes in this area
Musculoskeletal
4%Cyclooxygenase Inhibitor4%Ketorolac Tromethamine100%Part D≥79 patientsAnti-infectives
3.9%Fluoroquinolone Antibacterial3.2%Moxifloxacin100%Part D≥54 patientsTetracycline-class Drug0.7%Doxycycline Monohydrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2010–2025 per NIH RePORTER. The latest:
- Targeting Tissue Biomechanics for Treatment of Glaucoma
Vanderbilt University Medical Center
FY2025$456,985R01EY020894 - Targeting Tissue Biomechanics for Treatment of Glaucoma
Vanderbilt University Medical Center
FY2024$456,985R01EY020894 - Targeting Tissue Biomechanics for Treatment of Glaucoma
Vanderbilt University Medical Center
FY2023$456,985R01EY020894
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
William Schaffner, MD
Vanderbilt University
Keith Obstein, MD, MPH
Vanderbilt University
Andrew Jallouk, MD, PhD
Vanderbilt University
Salim Yusuf
Vanderbilt University
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”